Literature DB >> 20575032

A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines.

Takeshi Inukai, Xiuru Zhang, Takeshi Kameyama, Yukiko Suzuki, Kazuhito Yoshikawa, Itaru Kuroda, Atsushi Nemoto, Koshi Akahane, Hiroki Sato, Kumiko Goi, Kazunori Nakamoto, Jun-ichi Hamada, Mitsuhiro Tada, Tetsuya Moriuchi, Kanji Sugita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20575032      PMCID： PMC7159455          DOI： 10.1002/ajh.21738

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  23 in total

1.  p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?

Authors:  H G Drexler; S Fombonne; Y Matsuo; Z B Hu; H Hamaguchi; C C Uphoff
Journal:  Leukemia       Date:  2000-01       Impact factor: 11.528

2.  Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.

Authors:  K Akahane; T Inukai; T Inaba; H Kurosawa; A T Look; N Kiyokawa; J Fujimoto; H Goto; M Endo; X Zhang; K Hirose; I Kuroda; H Honna; K Kagami; K Goi; S Nakazawa; K Sugita
Journal:  Leukemia       Date:  2010-02-11       Impact factor: 11.528

3.  Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.

Authors:  M Wada; C R Bartram; H Nakamura; M Hachiya; D L Chen; J Borenstein; C W Miller; L Ludwig; T E Hansen-Hagge; W D Ludwig
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers.

Authors:  M Takahashi; H Tonoki; M Tada; H Kashiwazaki; K Furuuchi; J Hamada; Y Fujioka; Y Sato; H Takahashi; S Todo; N Sakuragi; T Moriuchi
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

6.  High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.

Authors:  H Kashiwazaki; H Tonoki; M Tada; I Chiba; M Shindoh; Y Totsuka; R Iggo; T Moriuchi
Journal:  Oncogene       Date:  1997-11-27       Impact factor: 9.867

7.  Distribution of TP53 mutations among acute leukemias with MLL rearrangements.

Authors:  C Lanza; G Gaidano; G Cimino; C Pastore; J Nomdedeu; G Volpe; C Vivenza; G Parvis; U Mazza; G Basso; E Madon; F Lo Coco; G Saglio
Journal:  Genes Chromosomes Cancer       Date:  1996-01       Impact factor: 5.006

8.  Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia.

Authors:  M B Diccianni; J Yu; M Hsiao; S Mukherjee; L E Shao; A L Yu
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

9.  Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.

Authors:  P Fenaux; P Jonveaux; I Quiquandon; C Preudhomme; J L Lai; M Vanrumbeke; M H Loucheux-Lefebvre; F Bauters; R Berger; J P Kerckaert
Journal:  Leukemia       Date:  1992-01       Impact factor: 11.528

10.  TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.

Authors:  Kanako Uno; Takeshi Inukai; Nobuhiko Kayagaki; Kumiko Goi; Hiroki Sato; Atsushi Nemoto; Kazuya Takahashi; Keiko Kagami; Noriko Yamaguchi; Hideo Yagita; Ko Okumura; Toshiko Koyama-Okazaki; Toshio Suzuki; Kanji Sugita; Shinpei Nakazawa
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.